Abaasa AM, Todd J, Ekoru K, Kalyango JN, Levin J, Odeke E, Karamagi CA (2008). Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv. Res. 8(1):241.
Crossref

Atnafu H, Wencheko E (2012). Factors affecting the survival of HIV-infected children after ART initiation in Bahir-Dar, Ethiopia. Ethiop. J. Health Dev. 26(3):193-199.

Ethiopian Central Stastical Autority (CSA) (2011). Ethiopian demographic and health survey(EDHS).

Ethiopian Fedral HIV/AIDS prevention and control office (FHAPCO)(2012). Contry progress report on HIV/aids response.

Federal Democratic Republic of Ethiopia Ministry of Health (2012/2013). Health sectore development programme IV performance report.

Fenner L, Brinkhof MW, Keiser O, Weigel R, Cornell M, Moultrie H, Prozesky H, Technau K, Eley B, Vaz P (2010). Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J. Acquir. Immune Defic. Syndr. 54(5):524.
Crossref

Fetzer BC, Hosseinipour MC, Kamthuzi P, Hyde L, Bramson B, Jobarteh K, Torjesen K, Miller WC, Hoffman I, Kazembe P, Mwansambo C (2009). Predictors for mortality and loss to follow‐up among children receiving anti‐retroviral therapy in Lilongwe, Malawi. Trop. Med. Int. Health 14(8):862-869.
Crossref

Koye DN, Ayele TA, Zeleke BM (2012). Predictors of mortality among children on Antiretroviral Therapy at a referral hospital, Northwest Ethiopia: a retrospective follow up study. BMC Pediatr. 12(1):161.
Crossref

Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, Yip B, Montaner JS (2009). The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J. Acquir. Immune Defic. Syndr. 50(5):529.
Crossref

Lumbiganon P, Kariminia A, Aurpibul L, Hansudewechakul R, Puthanakit T, Kurniati N, Kumarasamy N, Chokephaibulkit K, Nik Yusoff NK, Vonthanak S, Moy FS, Razali KA, Nallusamy R, Sohn AH (2011). Survival of HIV-infected children: A cohort study from the Asia- Pacific region. J. Acquir. Immune Defic. Syndr. 56(4):365-71.
Crossref

Maggiolo F, Airoldi M, Kleinloog HD, Callegaro A, Ravasio V, Arici C, Bombana E, Suter F (2007). Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-treated patients. HIV Clin. Trials 8(5):282-292.
Crossref

Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F (2004). Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364:1236-1243.
Crossref

O'brien DP, Sauvageot D, Olson D, Schaeffer M, Humblet P, Pudjades M, Ellman T, Zachariah R, Szumilin E, Arnould L, Read T (2007). Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor–based antiretroviral therapy in resource-limited settings. Clin. Infect. Dis. 44(9):1245-1248.
Crossref

Sunguya BF, Poudel KC, Otsuka K, Yasuoka J, Mlunde LB, Urassa DP, Mkopi NP, Jimba M (2011). Undernutrition among HIV-positive children in Dar es Salaam, Tanzania: antiretroviral therapy alone is not enough. BMC Public Health 11(1):869.
Crossref

Taye B, Shiferaw S, Enquselassie F (2010). The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART). Ethiop. Med. J. 48(1):1-10.

United Nations Program on HIV/AIDS(UNAIDS)(2013). Glaobal Report on Global AIDS epidemics.

World Health Organization (WHO) (2013a). Consolidated guidelines on the use of antiretroviral drugs for treating AND preventing HIV infection recommendations for a public health approach Report.

World Health Organization report (WHO) (2013b). United Nations International Children's Emergency Fund (UNICEF), Joint United Nations Programme on HIV and AIDS (UNAIDS) (2013). Global update on hiv treatment 2013: results, impact and opportunities.

Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME (2011). Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa. PloS one 6(7):e22706.
Crossref